Three months ago, the Food and Drug Administration placed a warning on the label for Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine related to potential rare blood clotting issues. In this Motley Fool Live video recorded on July 14, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss what investors should know about this latest FDA warning. The FDA has added a new warning to Johnson & Johnson's COVID-19 vaccine, and this is related to a very rare neurological disorder.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting